(Q73499922)

English

Doubling the omeprazole dose (40 mg b.d. vs. 20 mg b.d.) in dual therapy with amoxycillin increases the cure rate of Helicobacter pylori infection in duodenal ulcer patients

scientific article published on 01 June 1997

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9218075%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Doubling the omeprazole dose (40 mg b.d. vs. 20 mg b.d.) in dual therapy with amoxycillin increases the cure rate of Helicobacter pylori infection in duodenal ulcer patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9218075%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Helicobacter pylori

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Helicobacter pylori infectious disease

1 reference

based on heuristic

inferred from title

author name string

J. Labenz

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9218075

14 September 2024

J. A. Beker

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9218075

14 September 2024

C. P. Dekker

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9218075

14 September 2024

A. Farley

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9218075

14 September 2024

H. U. Klör

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9218075

14 September 2024

A. Jönsson

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9218075

14 September 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9218075

14 September 2024

publication date

1 June 1997

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9218075%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

full work available at URL

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2036.1997.00169.x

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9218075

14 September 2024

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2036.1997.00169.x

1 reference

10.1046/J.1365-2036.1997.00169.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00169.X

14 September 2024

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2036.1997.00169.x

1 reference

10.1046/J.1365-2036.1997.00169.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00169.X

14 September 2024

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9218075%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9218075%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9218075%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

515-522

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9218075%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence

2

1 reference

10.1046/J.1365-2036.1997.00169.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00169.X

14 September 2024

Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease

3

1 reference

10.1046/J.1365-2036.1997.00169.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00169.X

14 September 2024

Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse

4

1 reference

10.1046/J.1365-2036.1997.00169.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00169.X

14 September 2024

Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease

5

1 reference

10.1046/J.1365-2036.1997.00169.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00169.X

14 September 2024

Quality of life and relapse of duodenal ulcer before and after eradication of Helicobacter pylori.

7

1 reference

10.1046/J.1365-2036.1997.00169.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00169.X

14 September 2024

Costs of duodenal ulcer therapy with antibiotics

8

1 reference

10.1046/J.1365-2036.1997.00169.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00169.X

14 September 2024

Does omeprazole improve antimicrobial therapy directed towards gastric Campylobacter pylori in patients with antral gastritis? A pilot study.

11

1 reference

10.1046/J.1365-2036.1997.00169.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00169.X

14 September 2024

The Sydney System: histological division

13

1 reference

10.1046/J.1365-2036.1997.00169.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00169.X

14 September 2024

Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers

17

1 reference

10.1046/J.1365-2036.1997.00169.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00169.X

14 September 2024

Dose-response of omeprazole combined with amoxycillin on duodenal ulcer healing and eradication of Helicobacter pylori

18

1 reference

10.1046/J.1365-2036.1997.00169.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00169.X

14 September 2024

Intragastric acidity as a predictor of the success of Helicobacter pylori eradication: a study in peptic ulcer patients with omeprazole and amoxicillin

21

1 reference

10.1046/J.1365-2036.1997.00169.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00169.X

14 September 2024

Intravenous omeprazole: effect of a loading dose on 24-h intragastric pH.

22

1 reference

10.1046/J.1365-2036.1997.00169.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00169.X

14 September 2024

Metronidazole resistance: a predictor of failure of Helicobacter pylori eradication by triple therapy

27

1 reference

10.1046/J.1365-2036.1997.00169.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00169.X

14 September 2024

Dual therapy versus triple therapy for Helicobacter pylori-associated duodenal ulcers

30

1 reference

10.1046/J.1365-2036.1997.00169.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00169.X

14 September 2024

Amoxycillin capsules with omeprazole for the eradication of Helicobacter pylori. Assessment of the importance of antibiotic dose timing in relation to meals

32

1 reference

10.1046/J.1365-2036.1997.00169.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00169.X

14 September 2024

Omeprazole plus amoxicillin for cure of Helicobacter pylori infection. Factors influencing the treatment success

33

1 reference

10.1046/J.1365-2036.1997.00169.X

https://api.crossref.org/works/10.1046/J.1365-2036.1997.00169.X

14 September 2024

Identifiers

10.1046/J.1365-2036.1997.00169.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9218075%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9218075%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73499922&oldid=2247868440"